Ustekinumab in Crohn's disease: Real-world outcomes from the Sicilian network for inflammatory bowel diseases.

Anna ViolaMarco MuscianisiFabio Salvatore Macaluso Marco VentimigliaMaria CappelloAntonino C PriviteraAntonio MagnanoDario PluchinoGiovanni MagrìConcetta FerracaneFilippo MocciaroSerena GarufiEnrica GiuffridaGiuseppe CostantinoGabriele FioccoMauro GrovaLaura GuidaAngela AlibrandiAmbrogio OrlandoWalter Friesnull null

Published in: JGH open : an open access journal of gastroenterology and hepatology (2021)

Data from our real-life cohort of treatment-refractory CD patients suggest the satisfactory effectiveness and safety profile of ustekinumab.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
electronic health record
machine learning
combination therapy
smoking cessation
nk cells